Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Crotty

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Intellectual Disabilities : JOID|December 17, 2015
Transcultural care and individuals with an intellectual disabilityGerard Crotty, Owen Doody
Journal of Intellectual Disabilities : JOID|November 6, 2013
Aggressive behaviour and its prevalence within five typologiesGerard Crotty, Owen Doody, Rosemary Lyons
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 19, 2010
Evaluation of bone marrow examinations performed by an advanced nurse practitioner: an extended role within a haematology serviceMary Kelly, Gerard Crotty, Kanthi Perera, et al.
Case Reports in Hematology|August 24, 2013
Nonfamilial, MPL S505N-Mutated Essential ThrombocythaemiaRuth Morrell, Stephen E Langabeer, Liam Smyth, et al.
Irish Journal of Medical Science|October 17, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemiasHelen Fogarty, Anita Dowling, David O'Brien, et al.
Leukemia & Lymphoma|September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLLNiamh Appleby, David O'Brien, Fiona M Quinn, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2020
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With LenalidomideBarbara Gamberi, Christian Berthou, Miguel Hernandez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Intellectual Disabilities : JOID|December 17, 2015
Transcultural care and individuals with an intellectual disabilityGerard Crotty, Owen Doody
Journal of Intellectual Disabilities : JOID|November 6, 2013
Aggressive behaviour and its prevalence within five typologiesGerard Crotty, Owen Doody, Rosemary Lyons
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 19, 2010
Evaluation of bone marrow examinations performed by an advanced nurse practitioner: an extended role within a haematology serviceMary Kelly, Gerard Crotty, Kanthi Perera, et al.
Case Reports in Hematology|August 24, 2013
Nonfamilial, MPL S505N-Mutated Essential ThrombocythaemiaRuth Morrell, Stephen E Langabeer, Liam Smyth, et al.
Irish Journal of Medical Science|October 17, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemiasHelen Fogarty, Anita Dowling, David O'Brien, et al.
Leukemia & Lymphoma|September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLLNiamh Appleby, David O'Brien, Fiona M Quinn, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2020
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With LenalidomideBarbara Gamberi, Christian Berthou, Miguel Hernandez, et al.
Pageof 1